Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy

Please use this identifier to cite or link to this item: http://cmuir.cmu.ac.th/jspui/handle/6653943832/51070

Title:	Persistence of measles, mumps, and rubella protective antibodies 3 years after revaccination in HIV-infected children receiving antiretroviral therapy
Authors:	Linda Aurpibul Thanyawee Puthanakit Thira Sirisanthana Virat Sirisanthana
Authors:	Linda Aurpibul Thanyawee Puthanakit Thira Sirisanthana Virat Sirisanthana
Keywords:	Medicine
Issue Date:	15-May-2010
Abstract:	Three years after measles, mumps, and rubella revaccination in 38 human immunodeficiency virus-infected children who had achieved immune recovery after antiretroviral therapy, the prevalence of protective antibody levels was 85% for measles, 61% for mumps, and 79% for rubella, compared with 88%, 84%, and 100%, respectively, 1 month after revaccination. © 2010 by the Infectious Diseases Society of America. All rights reserved.
URI:	https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77951814475&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/51070
ISSN:	10584838
Appears in Collections:	CMUL: Journal Articles

Files in This Item:

There are no files associated with this item.